Literature DB >> 24895634

Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico.

Daniela A López-Banda1, Erika M Carrillo-Casas2, Margarita Leyva-Leyva2, Gabriel Orozco-Hoyuela3, Ángel H Manjarrez-Hernández4, Sara Arroyo-Escalante2, David Moncada-Barrón5, Silvia Villanueva-Recillas5, Juan Xicohtencatl-Cortes6, Rigoberto Hernández-Castro1.   

Abstract

E coli isolates (108) from Mexican women, clinically diagnosed with urinary tract infection, were screened to identify virulence genes, phylogenetic groups, and antibiotic resistance. Isolates were identified by MicroScan4 system; additionally, the minimum inhibitory concentration (MIC) was assessed. The phylogenetic groups and 16 virulence genes encoding adhesins, toxins, siderophores, lipopolysaccharide (LPS), and invasins were identified by PCR. Phylogenetic groups distribution was as follows: B1 9.3%, A 30.6%, B2 55.6%, and D 4.6%. Virulence genes prevalence was ecp 98.1%, fimH 86.1%, traT 77.8%, sfa/focDE 74.1%, papC 62%, iutA 48.1%, fyuA 44.4%, focG 2.8%, sfaS 1.9%, hlyA 7.4%, cnf-1 6.5%, cdt-B 0.9%, cvaC 2.8%, ibeA 2.8%, and rfc 0.9%. Regarding antimicrobial resistance it was above 50% to ampicillin/sulbactam, ampicillin, piperacillin, trimethoprim/sulfamethoxazole, ciprofloxacin, and levofloxacin. Uropathogenic E. coli clustered mainly in the pathogenic phylogenetic group B2. The isolates showed a high presence of siderophores and adhesion genes and a low presence of genes encoding toxins. The high frequency of papC gene suggests that these isolates have the ability to colonize the kidneys. High resistance to drugs considered as first choice treatment such as trimethoprim/sulfamethoxazole and fluoroquinolones was consistently observed.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24895634      PMCID： PMC4026957          DOI： 10.1155/2014/959206

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Introduction

Urinary tract infections (UTI) are one of the most common infections worldwide. Uropathogenic Escherichia coli (UPEC) is the primary pathogen causing UTIs; it colonizes the human intestine a few hours after birth and is considered part of the normal microbiota. However, it can cause various diseases such as diarrhea, UTI, and meningitis [1]. It is classified into three groups: (i) commensal, (ii) intestinal pathogenic, and (iii) extraintestinal pathogenic [2], and phylogenetically it has been classified into four classic groups (A, B1, B2, and D) [3]. Uropathogenic E. coli is located within the extraintestinal pathogenic E. coli (ExPEC), classified primarily into the phylogenetic group B2 and to a lesser extent to group D, whereas commensal strains are within the phylogenetic groups A and B1 [4-8]. The ability of E. coli to colonize different anatomical sites is due in part to genome plasticity and remodeling by acquisition or loss of genetic material from which it acquired resistance or virulence factors. Therefore, horizontal transfer is an important factor in the evolution and adaptation of E. coli to different niches [9, 10]. The interaction between bacteria and epithelial cells is a multifactorial and complex phenomenon which involves several adhesins produced according to the stage of infection, while adherence to epithelial cells is essential for successful colonization and establishment; the expression of other genes encoding toxins, siderophores, lipopolysaccharide (LPS), capsule, and invasins determines the disease severity and the strain's virulence [8]. UPEC strains can cause acute infections and recurrent infections that do not respond to common antimicrobial treatments. UTI treatment generally includes β-lactam antibiotics, fluoroquinolones, or trimethoprim/sulfamethoxazole [11-13] but may vary according to patient age, sex, Pathogen involved, course of disease, and the urinary tract anatomic area involved [5]. The increased resistance may be related to changes in the bacterial genome by mutation or acquisition by horizontal transfer of an extrachromosomal or chromosomal material [14-16]. Urinary tract successful invasion depends on the bacteria virulence, inoculums size, and the host's defense mechanisms [18]. However, women have higher UTI's prevalence and incidence mainly due to their anatomical characteristics such as the proximity between the anus and the urethral opening, hormone effects, and changes in the genital microbiota [14, 19]. Clinically a UTI is defined by a bacteriuria with a count in midstream urine culture ≥105 CFU/mL and pyuria or the presence of white blood cells in the urine, more than five leukocytes per field [19]. Globally it is estimated that about 150 million UTIs occur annually [20]. In the United States and Spain the current situation and treatment of urinary tract infections had been thoroughly described [6–8, 18]; it is estimated that 11% of women experience at least one diagnosis of urinary tract infection (UTI) per year, and 60% of women will have or have had an UTI or more during their lifetime [4]. In Mexico UTI's status has not been described. However, to our knowledge it is E. coli one of the pathogenic agents of UTI and it is more frequent in women, with high incidence and prevalence, representing a costly problem for the health sector [4, 21]. In 2008, 3,244,994 cases were reported, which represents an incidence of 3,041.7/100,000 inhabitants, from which 75.6% (2,453,608/100,000 inhabitants) were women, representing an incidence of 4,508.6/100,000. The present study aimed to describe the profile of E. coli from Mexican women with urinary tract infection by the identification of virulence genes (fimH, papC, sfa/focDE, sfaS, focG, ecpA, ecpR-B, hlyA, cnf-1, cdt-B, cvaC, iutA, ibeA, rfc, tratT, and fyuA), phylogenetic group, and their resistance to antibiotics to guide better diagnosis and treatment of UTI.

2. Material and Method

2.1. Bacteria and Culture

Bacterial isolates (108) were obtained from urine samples from women diagnosed with acute urinary tract infection and confirmed by the clinical laboratory of the General Hospital “Dr. Manuel Gea Gonzalez” during 2008 and until 2010. All samples with counts over 100,000 UFC/mL were included. Patients were within an age range between 12 and 58 years and mean age of 38.9 years. Isolates were identified by MicroScan 4 (Dade Behring) automated system. The presence of β-lactamases and the minimum inhibitory concentration (MIC) were also determined for ampicillin, ampicillin/sulbactam, amoxicillin/clavulanic acid, aztreonam, imipenem, meropenem, piperacillin, piperacillin/tazobactam, ticarcillin/clavulanic acid, amikacin, gentamicin, tobramycin, ceftriaxone, ceftazidime, cefotaxime, cefoxitin, cephalotin, cefazolin, cefepime, cefuroxime, cefotetan, trimethoprim/sulfamethoxazole, ciprofloxacin, gatifloxacin, levofloxacin, and moxifloxacin. The antibiotic resistance was classified into sensitive, resistant, and ESBL (resistance due to β-lactamases). Pure cultures were maintained at −70°C in brain-heart infusion broth/glycerol 50%. The E. coli CFT073 uropathogenic strain was used as control strain.

2.2. Phylogenetic Groups and Virulence Factors

The PCR was performed with the GoTaq Flexi kit (Promega) according to the manufacturer's instructions. Phylogenetic groups were identified according to Clermont protocol [22]. 16 virulence genes of UPEC were included: fimH, papC, sfa/focDE, sfaS, focG, ecpA, ecpR-B, hlyA, cnf-1, cdt-B, cvaC, iutA, ibeA, rfc, tratT, and fyuA. PCR primers and conditions for each gene are described in Tables 1 and 2 [5, 17]. The ecp RB PCR was performed to overcome the possible variation of ecpA which may give a false negative result of the E. coli common pilus [17]. All PCR products were visualized in agarose gel stained with ethidium bromide.
Table 1

PCR primer for each virulence factor. Primer sequence was taken from Johnson and Stell, 2000 [5] and Blackburn et al., 2009 [17].

GenesPrimer (5′-3′)
ecpA TGA AAA AAA AGG TTC TGG CAA TAG C
CGC TGA TGA GGA GAA AGT GAA
ecpRB GTC ACA TGG CAA AAT GAT TAC AGC
TCA CGG GAA TGA ACT TAT CAC CC
papC GTG GCA GTA TGA GTA ATG ACC GTT A
ATA TCC TTT CTG CAG GGA TGC AAT A
sfaS GTG GAT ACG ACG ATT ACT GTG
CCG CCA GCA TTC CCT GTA TTC
focG CAG CAC AGG CAG TGG ATA CGA
GAA TGT CGC CTG CCC ATT GTC
fimH TGC AGA ACG GAT AAG CCG TGG
GCA GTC ACC TGC CCT CCG GTA
sfa/fogDE CTC CGG AGA ACT GGG TGC ATC TTA C
CGG AGG AGT AAT TAC AAA CCT GGC A
cnf1 AAG ATG GAG TTT CCT ATG CAG GAG
CAT TCA GAG TCC TGC CCT CAT TAT T
hlyA AAC AAG GAT AAG CAC TGT TCT GGC T
ACC ATA TAA GCG GTC ATT CCC GTC A
cdt-s GAA AGT AAA TGG AAT ATA AAT GTC CG
GAA AAT AAA TGG AAC ACA CAT GTC CG
cdt-a AAA TCA CCA AGA ATC ATC CAG TTA
AAA TCT CCT GCA ATC ATC CAG TTT A
colV CAC ACA CAA ACG GGA GCT GTT
CTT CCC GCA GCA TAG TTC CAT
fyuA TGA TTA ACC CCG CGA CGG GAA
CGC AGT AGG CAC GAT GTT GTA
iutA GGC TGG ACA TCA TGG GAA CTG G
CGT CGG GAA CGG GTA GAA TCG
ibeA AGG CAG GTG TGC GCC GCG TAC
TGG TGC TCC GGC AAA CCA TGC
Rfc ATC CAT CAG GAG GGG ACT GGA
AAC CAT ACC AAC CAA TGC GAG
traT GGT GTG GTG CGA TGA GCA CAG
CAC GGT TCA GCG ATC CCT GAG
Table 2

PCR conditions for each gene.

GenesInicial denaturation(°C/min)Denaturation(°C/s)Annealing(°C/s)Extension(°C/s)Final extention (°C/min)Cycles
ecpA 96/594/3062/4572/4572/535
ecpR-B 95/595/3057.5/3372/9075/535
fimH 96/594/3065.5/3072/3072/535
papC 95/594/3058.2/3072/4072/540
sfaS 95/594/3064/3072/2572/535
fogG 95/595/3064/4072/3072/530
sfa/focDE 95/594/3065/3068/4072/335
cnf-1 95/594/3065.5/3072/3072/535
hlyA 95/594/3063/3068/6072/530
Mu lt i1*95/594/3067.1/3068/16072/530
Mu lt i2**95/594/3061.5/3068/18072/535
Rfc 95/595/3062.5/3072/6075/540

*Multiplex 1 for genes fyuA, iutA e ibeA.**Multiplex 2 for genes cdtB, cvaC y traT.

2.3. Statistical Analysis

To establish the results significance, the Fisher exact test was used. The level of significance was set at a P value of ≤0.05.

3. Results

The overall results of the isolates regarding the virulence genes, the phylogenetic group, and resistance profile are shown in Table 3. Regarding the phylogenetic group, most of the isolates were (60) grouped into the B2 group (55.6%), 33 isolates were classified as part of the A group (30.6%), 10 isolates (9.3%) to group B1, and 5 isolates (4.6%) to group D.
Table 3

Virulence genes and phylogenetic group.

# Strain Ecp fimH papC sfa/focDE focG sfaS hlyA cnf-1 cdtB cvaC iutA ibeA Rfc traT fyuA chuA yja TSP PG
1++++−−−−−+++−+++++B2
2++−−−−−−−−+−−+++−−D
3+++−−−−−−−+−−+++++B2
4++++−−−−−−−−−−−−+−A
5++++−−−−−−−−−−−−+−A
6+++−−−−−−−+−−++−+−A
7++++−−−−−−+−−++++−B2
8+−++−−−−−−+−−+++++B2
9++++−−−−−−−−−−−−+−A
10++++−−−−−−−−−++++−B2
11+−++−−−−−−−−−+−−+−A
12−++−−−−−−−+−−+++++B2
13++++−−−−−−+−−+++++B2
14++++−−−−−−−−−−−++−B2
15+−++−−−−−−+−−+++++B2
16++++−−−−−−+−−+−−+−A
17++++−−−−−−+−−+−−+−A
18++++−−−−−−+−−++++−B2
19++−+−−−−−−+−−+++++B2
20++++−−−−−−−−−+−−++B1
21++++−−−−−−+−−++++−B2
22++++−−−−−−−−−+−+++B2
23++++−−−−−−+−−++−−−A
24++++−−−−−−−−−+−+++B2
25++++−−−−−−−−−−−−+−A
26−+++−−−−−−−−−+−++−B2
27++++−−−−−−−−−+−++−B2
28++−+−−−−−−+−−+++++B2
29++−+−−−−−−−−−−−+−−D
30+++++−++−−−−−+++++B2
31++−+−−−−−−+−−++−++B1
32++++−−++−−−−−+−+++B2
33++−+−−−−−−−−−−−++−B2
34+++−−−−−−−−−−++−+−A
35++−+−−−−−−+−−−++++B2
36++−+−−−−−−−−−+−+−−D
37+++−−−−−−−+−−+++++B2
38+++−−−−−−−−−−+−+++B2
39++++−−−−−−+−−+−+−−D
40++++−−−−−−−−−+−++−B2
41+++−−−−−−−+−−+++++B2
42++−−−−−−−−+−−+++++B2
43++−−−−−−−−−−−++−−−A
44++−−−−−−−−−−−−−−+−A
45++++−−−−−−−−−−−−+−A
46++++−−−−−−+−−++++−B2
47++++−−−−−−+−−++++−B2
48++++−−−−−−−−−−−−+−A
49++−+−−−−−−−−−++++−B2
50++−+−−−−−−−−−++−+−A
51++++−−−−−−−−−−−+++B2
52++++−−−−−−−−−−−−+−A
53++−−−−−−−−−−−−−−+−A
54+++−−−−−−−−−−++++−B2
55+++++−−−−++−−+−++−B2
56++++−−−−−−+−−+−−+−A
57+++−−−−−−−+−−+++++B2
58+−+−−−−−−−−−−−−−−+B1
59++++−−−−−−−−−−−+−+D
60+−+−−−−−−−+−−−−−+−A
61++−+−−−−−−−−−−−−−−A
62++−−−−−−−−+−−+++++B2
63++++−−−−−−+−−+++++B2
64++−−−−−−−−+−−+++++B2
65+++−−−−−−−+−−−++++B2
66+++++−++−−−−−+−+++B2
67+++−−−−−−−−−+−−−++B1
68++−+−−−−−−−−−+−+++B2
69++++−−−−−−−−−+−++−B2
70++−−−−−−−−−−−++−+−A
71++++−−−−−−+−−+−−+−A
72++−+−−−−−−−−−−−−−−A
73++−+−−−−−−−−−+−−+ A
74++++−+++−−−−−+++++B2
75++−−−−−−−−+−−++++−B2
76+−−−−−−−−−−−−+−−+−A
77++−+−−−−−−−−−++++−B2
78++−−−−−−−−−−−+−−+−A
79++−+−−−−−−+−−−−++−B2
80++++−−−−−−−−−−−++−B2
81++++−−−−−−+−−+++++B2
82++−+−−−−−−−−−++−+−A
83++++−+++−−+−−+++++B2
84+−++−−−−−−+−−+−−+−A
85+−++−−−−−−−−−+−−+−A
86+++−−−−−−−+−−+++++B2
87++−−−−−−−−+−−+−−+−A
88+++−−−−−−−−−−+−−+−A
89++−+−−−−−−−−−++−++B1
90++++−−−−−−+−−+−−++B1
91+−−+−−−−−−−−−−−−++B1
92+−++−−−−−−−−−+−−++B1
93++++−−−−−−−−−+−−++B1
94++++−−−+−−+−−++++−B2
95++++−−−−−−+−−+++++B2
96++++−−+−−−+−−+++++B2
97+−−+−−−−−−−−−+−−+−A
98++++−−+++−+−−+++++B2
99++−+−−−−−−−−−+−+++B2
100++−+−−−−−−+−−+++++B2
101++−+−−−−−−+−−+++++B2
102++−−−−−−−−++−+−−++B1
103+−−+−−−−−−+−−+−++−B2
104+−−+−−−−−+++−+−+++B2
105++−+−−+−−−+−−+−+++B2
106++−+−−−−−−+−−+−+++B2
107+−−+−−−−−−−−−+−−+−A
108+−−+−−−−−−−−−+−+++B2

Phylogenetic group (PG).

3.1. Virulence Genes

Higher prevalence, above 50%, was observed for the ecp, fimH, traT, sfa/focDE, and papC genes (98.1%, 86.1%, 77.8%, 74.1%, and 62%, resp.). For iutA and fyuA genes prevalence was close to 50% (48.1% and 44.4%, resp.), while the focG, sfaS, hlyA, cnf-1, cdt-B, cvaC, ibeA, and rfc genesregistered prevalence lower than 10% (2.8%, 1.9%, 7.4%, 6.5%, 0.9%, 2.8%, 2.8%, and 0.9%, resp.). Table 4 shows the distribution of virulence genes regarding the phylogenetic group. Most of the virulence factors associated with the phylogenetic group B2 were identified. The ecp (A and R-B) and fimH genes are widely distributed among all groups (A 100%/78.8%, B1 100%/70%, B2 96.7%/91.7%, and D 100%/100%, resp.). The focG, sfaS, hlyA, cnf-1, cdt-B, and cvaC genes were found only in isolates from the B2 group. The rfc gene was found in just one isolate from group B1. The hlyA, cft-1, and traT genes were positively associated with group B2, and the iutA and fyuA genes were negatively associated with group A.
Table 4

Relation among phylogenetic group and virulence genes.

GenePhylogenetic group (n, %)
A (n = 33)B1 (n = 10)B2 (n = 60)D (n = 5)
Ecp 33 (100)10 (100)58 (96.7)5 (100)
fimH 26 (78.8)7 (70)55 (91.7)5 (100)
papC 19 (57.6)6 (60)40 (66.7)2 (40)
sfa/focDE 22 (66.7)7 (60)47 (78.3)4 (80)
focG 003 (5)0
sfaS 002 (3.3)0
hlyA 008 (13.3)a 0
cnf-1 007 (11.7)a 0
cdt-B 001 (1.7)0
cvaC 003 (5)0
iutA 9 (27.3)(a) 3 (30)38 (63.3)a 2 (40)
ibeA 01 (10)2 (3.3)0
Rfc 01 (10)0 0
traT 21 (63.6)7 (70)53 (88.3)a 3 (60)
fyuA 7 (21.2)(a) 2 (20)38 (63.3)a 1 (20)

a P values were calculated by comparison of each group with Fisher's exact test.

Statistic significance of ≤0.05(a) negative association.

3.2. Antibiotic Resistance

Above 50% of antibiotic resistance was observed for ampicillin/sulbactam (75.9%), ampicillin (55.2%), piperacillin (51.1%), trimethoprim/sulfamethoxazole (56.1%), ciprofloxacin (62.3%), gatifloxacin (62.5%), levofloxacin (60.2%), and moxifloxacin (52.6%). Sensitivity values above 50% were found to amoxicillin/clavulanic acid (68.8%), aztreonam (78.4%), imipenem (98.1%), meropenem (100%), piperacillin/tazobactam (86%), ticarcillin/clavulanic acid (58.2%), amikacin (93.5%), gentamicin (72.2%), tobramycin (56.5%), ceftriaxone (78.1%), ceftazidime (77.9%), cefotaxime (78.9%), cefoxitin (91.1%), cefazolin (65.9%), cefepime (78.1%), cefuroxime (71.1%), and cefotetan (98.4%). Approximately 20% of isolates registered the presence of β-lactamases and around 20% were resistant to antimicrobials, as shown in Table 5. Isolates which displayed resistance to more than ≥3 chemotherapeutic groups were considered multiresistant isolates, which represents 58%. However no statistical relation was observed among multiresistance and phylogenetic group (Table 6).
Table 5

Antibiotic resistance.

Antibiotic (number of isolates) S (%) R (%)ESBL (%)
ampicillin/sulbactam (108)26 (24.1)82 (75.9)0
ampicillin (97)22 (22.7)54 (55.7)21 (21.9)
amoxicillin/clavulinic acid (64)44 (68.8)20 (31.3)0
aztreonam (97)76 (78.4)021 (21.6)
Imipenem (108)106 (98.1)2 (1.9)0
Meropenem (30)30 (100)00
piperacillin/tazobactam (107)92 (86)15 (14)0
piperacillin (95)25 (26.3)49 (51.6)21 (22.3)
ticarcillin/clavulanic acid (91)53 (58.2)38 (41.8)0
amikacin (108)101 (93.5)7 (6.5)0
gentamicin (108)78 (72.2)30 (27.8)0
tobramycin (108)61 (56.5)47 (43.5)0
ceftriaxone (96)75 (78.1)021 (21.9)
ceftazidime (95)74 (77.9)021 (22.1)
cefotaxime (76)60 (78.9)016 (21.1)
cefoxitin (45)41 (91.1)4 (8.9)0
cephalotin (22)10 (45.5)8 (36.4)4 (18.2)
cefazolin (91)60 (65.9)11 (12.1)20 (22)
cefepime (96)75 (78.1)021 (21.9)
cefuroxime (56)40 (71.4)1 (1.8)15 (26.8)
cefotetan (61)60 (98.4)1 (1.6)0
trimethoprim/sulfamethoxazole (107)47 (43.9)60 (56.1)0
ciprofloxacin (106)40 (37.7)66 (62.3)0
gatifloxacin (64)24 (37.5)40 (62.5)0
levofloxacin (108)43 (39.8)65 (60.2)0
moxifloxacin (19)9 (47.4)10 (52.6)0
Table 6

Relation among multidrug resistance and phylogenetic group.

Phylogenetic groupMultidrug resistance [positive isolates number (%)]
No-MDS (n = 45)MDS (n = 63)
A11 (24.4)22 (34.9)
B16 (13.3)4 (6.4)
B224 (53.3)36 (57.1)
D4 (9)1 (1.6)

MDS: multidrug sensitive. P values were calculated by the Fisher's exact test for each group, none has statistical significance value ≤0.05.

4. Discussion

In this work 108 E. coli isolates were screened from female patients with an average age of 39 years; women were regarded as a productive population, for which urinary tract infections are considered a major cause of morbidity in our country and represent a huge economic impact [23, 24]. The predominant phylogenetic group was B2 (55.6%), widely associated with pathogenic strains. In Spain and the United States similar results had been reported and also a lower percentage related to the phylogenetic group D [6–8, 18, 25]. The phylogenetic group A, associated with commensal strains, represents a 30.6%, higher than in other studies, suggesting that the gastrointestinal tract is the main reservoir of strains that may be able to colonize the urinary tract in accordance to previous observations [6, 7, 18, 25]. The B1 group (9.3%) as a cause of urinary tract infections points out the high plasticity of the E coli genome which allowed the presence of the fimH, papC, and ecp (A and RB) in percentages of 70%, 60%, and 100%, respectively. These genes are related to the ability to colonize the urinary tract epithelium [18, 22, 26–28]. Adhesins genes were present in high percentages: fimH (86.1%), ecp (A y R-B) (98.1%), and papC (62%), this result could be related to the pathogenicity of the isolated strains as adherence is the most important pathogenicity determinant [4]. The fimH geneonce again was highly conserved in UTI isolates which confirms its crucial role during colonization of the urinary tract [4, 29–32]. The ecp (A and RB) gene is associated with commensals and enteropathogenic strains; it was present in 98.1% of this study isolates and according to a similar observation in Portugal it was found in 100% of their isolates; it may be associated with UPEC [17, 22, 24, 28]. The papC gene encodes an outer membrane protein essential for the fimbriae P biogenesis regulation. pap genes presence had been associated with pyelonephritis; therefore, higher percentages (over 50%) suggest that the strains isolated from the Mexican population have greater capabilities to colonize kidneys and generate pyelonephritis [32, 33]. The hlyA and cnf-1 genes showed a positive relationship with the B2 group; also they are associated with pathogenicity island PAI IIJ96, and the iutA gene is associated with pathogenicity island PAI ICFT073 as well as with hlyA and pap operon [8, 19, 34–36]. The sfaS gene was found exclusively in hlyA and cnf-1 positive isolates which could be linked to cystitits cases. This observation is in accordance with the previous report by Lloyd et al. [19]. The cvaC gene was present in only three isolates traT positive. These genes are both located at the colV plasmid. traT is related to the phylogenetic group B2, and presumes an animal source. The iutA and fyuA genesalso showed a relation with the phylogenetic group B2 [37-39]. The ibeA gene, related to the B2 group, was found in an isolate identified as B1, a result that may start to change the previous assumption [40]. The rfc gene was identified in just one isolate which indicates that the serogroup O4 was not the predominant serogroup in the population studied and that this result may need further serological confirmation [5, 41]. The treatment of choice for ITU is in order of importance: fluoroquinolones (ciprofloxacin), the trimethoprim/sulfamethoxazole, cephalosporins, and penicillins (ampicillin) to which an increasingly developed resistance has been reported due mainly to the indiscriminated antibiotic use [13, 14]. In this work it is confirmed the resistance previously reported values for trimethoprim/sulfamethoxazole (56.1%) [14, 42]; for ciprofloxacin (62.3%), gatifloxacin, levofloxacin, and moxifloxacin, resistance was always above 50%. Positive isolates to hlyA, cnf-1, and/or papC genes were susceptible to fluoroquinolones, results similar to those of Piatti et al. [43]. Besides in Mexico, the previously reported E. coli resistance profile included ampicillin, piperacillin, fluoroquinolones, and trimethoprim/sulfamethoxazole which are considered to be first-line choices [13, 44, 45]. Additionally, serotype 025b-ST131 has been reported to be within the Mexican population which has been associated with plasmid mediated quinolone resistance [46]. We had identified multidrug resistance of the E. coli strains causing UTI in 58% of the isolates which belonged mainly to group B2, result which kept our attention.

5. Conclusion

This work confirms that most of the isolates associated with urinary tract infections belong to the phylogenetic group B2 and in a lesser extent to group D. Also they displayed a great number of virulence genes. However, commensal strains may also be the cause of UTI. According to our results most parts of the isolates have the ability to colonize the kidneys as they have a high incidence of the papC gene. The hlyA and cnf-1 genes encoding toxins and fyuA iutA and siderophores encoding genes are tightly associated with the phylogenetic group B2. E. coli has successfully adapted to host's conditions and to the general medical practices as we may observe the high resistance to trimethoprim/sulfamethoxazole and fluoroquinolones, especially on the most frequently isolated phylogenetic groups. Finally, these results reinforce international knowledge on antimicrobial resistance and the high rate of multidrug resistance found invites us to encourage population awareness of the proper use of antimicrobials.
  44 in total

Review 1.  Secreted proteins and other features specific to uropathogenic Escherichia coli.

Authors:  D M Guyer; N W Gunther ; H L Mobley
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

Review 2.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

3.  Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains.

Authors:  Martine Bingen-Bidois; Olivier Clermont; Stéphane Bonacorsi; Mustapha Terki; Naïma Brahimi; Chawki Loukil; Dominique Barraud; Edouard Bingen
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.

Authors:  James R Johnson; Michael A Kuskowski; Abby Gajewski; Daniel F Sahm; James A Karlowsky
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

5.  Molecular epidemiology of Escherichia coli O25b-ST131 isolates causing community-acquired UTIs in Mexico.

Authors:  Fernando Reyna-Flores; Humberto Barrios; Ulises Garza-Ramos; Alejandro Sánchez-Pérez; Teresa Rojas-Moreno; Felipe J Uribe-Salas; Reynero Fagundo-Sierra; Jesus Silva-Sanchez
Journal:  Diagn Microbiol Infect Dis       Date:  2013-07       Impact factor: 2.803

6.  Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7.

Authors:  Juan Xicohtencatl-Cortes; Valério Monteiro-Neto; Maria A Ledesma; Dianna M Jordan; Olivera Francetic; James B Kaper; José Luis Puente; Jorge A Girón
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method.

Authors:  David M Gordon; Olivier Clermont; Heather Tolley; Erick Denamur
Journal:  Environ Microbiol       Date:  2008-06-02       Impact factor: 5.491

8.  Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women.

Authors:  Eva Moreno; James R Johnson; Teresa Pérez; Guillem Prats; Michael A Kuskowski; Antonia Andreu
Journal:  Microbes Infect       Date:  2008-12-13       Impact factor: 2.700

9.  Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period.

Authors:  Hong Bin Kim; Chi Hye Park; Chung Jong Kim; Eui-Chong Kim; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633
View more
  14 in total

1.  Genotypic Characterization of Virulence Factors in Escherichia coli Isolated from Patients with Acute Cystitis, Pyelonephritis and Asymptomatic Bacteriuria.

Authors:  Mohsen Tabasi; Mohammad Reza Asadi Karam; Mehri Habibi; Ehsan Mostafavi; Saeid Bouzari
Journal:  J Clin Diagn Res       Date:  2016-12-01

2.  Antibiotic resistance, phylogenetic typing, and virulence genes profile analysis of uropathogenic Escherichia coli isolated from patients in southern Iraq.

Authors:  Mohammed Allami; Masoumeh Bahreini; Mohammad Reza Sharifmoghadam
Journal:  J Appl Genet       Date:  2022-02-10       Impact factor: 3.240

3.  Study of Antibacterial Chemical Substances and Molecular Investigation among Sulfamethoxazole-trimethoprim (SXT)-Resistant Escherichia coli Isolates.

Authors:  Ruaa Ali Muhammed Ali; Jamal Mohammed Ridha Alshara; Nabil Salim Saaid Tuwaij; Huda Jameel Baker Al-Khilkhali
Journal:  Rep Biochem Mol Biol       Date:  2022-04

4.  Virulence factors analysis and antibiotic resistance of uropathogenic Escherichia coli isolated from patients in northeast of Iran.

Authors:  Mahdis Ghavidel; Tahere Gholamhosseini-Moghadam; Kimiya Nourian; Kiarash Ghazvini
Journal:  Iran J Microbiol       Date:  2020-06

5.  Multidrug- and Extensively Drug-Resistant Uropathogenic Escherichia coli Clinical Strains: Phylogenetic Groups Widely Associated with Integrons Maintain High Genetic Diversity.

Authors:  Sara A Ochoa; Ariadnna Cruz-Córdova; Victor M Luna-Pineda; Juan P Reyes-Grajeda; Vicenta Cázares-Domínguez; Gerardo Escalona; Ma Eugenia Sepúlveda-González; Fernanda López-Montiel; José Arellano-Galindo; Briceida López-Martínez; Israel Parra-Ortega; Silvia Giono-Cerezo; Rigoberto Hernández-Castro; Daniela de la Rosa-Zamboni; Juan Xicohtencatl-Cortes
Journal:  Front Microbiol       Date:  2016-12-21       Impact factor: 5.640

6.  First Indian report on genome-wide comparison of multidrug-resistant Escherichia coli from blood stream infections.

Authors:  Naveen Kumar Devanga Ragupathi; Balaji Veeraraghavan; Dhiviya Prabaa Muthuirulandi Sethuvel; Shalini Anandan; Karthick Vasudevan; Ayyan Raj Neeravi; Jones Lionel Kumar Daniel; Sowmya Sathyendra; Ramya Iyadurai; Ankur Mutreja
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

7.  The Vacuolating Autotransporter Toxin (Vat) of Escherichia coli Causes Cell Cytoskeleton Changes and Produces Non-lysosomal Vacuole Formation in Bladder Epithelial Cells.

Authors:  Juan Manuel Díaz; Charles M Dozois; Francisco Javier Avelar-González; Eduardo Hernández-Cuellar; Pravil Pokharel; Alfredo Salazar de Santiago; Alma Lilian Guerrero-Barrera
Journal:  Front Cell Infect Microbiol       Date:  2020-06-26       Impact factor: 5.293

8.  Features of urinary Escherichia coli isolated from children with complicated and uncomplicated urinary tract infections in Mexico.

Authors:  Víctor M Luna-Pineda; Sara A Ochoa; Ariadnna Cruz-Córdova; Vicenta Cázares-Domínguez; Juan P Reyes-Grajeda; Marco A Flores-Oropeza; José Arellano-Galindo; Rigoberto Hernández-Castro; Marcos Flores-Encarnación; Adriana Ramírez-Vargas; Héctor J Flores-García; Leticia Moreno-Fierros; Juan Xicohtencatl-Cortes
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

9.  Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients.

Authors:  Mohammad Mohammadzadeh; Mahnaz Tavakoli; Somayeh Yaslianifard; Ehsan Asadi; Reza Golmohammadi; Reza Mirnejad
Journal:  Infect Drug Resist       Date:  2019-07-09       Impact factor: 4.003

10.  Phylogenetic Group/Subgroups Distributions, Virulence Factors, and Antimicrobial Susceptibility of Escherichia coli Strains from Urinary Tract Infections in Hatay.

Authors:  Ebru Şebnem Yılmaz; Özkan Aslantaş
Journal:  Rev Soc Bras Med Trop       Date:  2020-02-07       Impact factor: 1.581
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.